PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

類似資料

• HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis
  著者:: Messai, Yosra, 等
  出版事項: (2015)
• The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
  著者:: Noman, Muhammad Zaeem, 等
  出版事項: (2017)
• Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
  著者:: Noman, Muhammad Zaeem, 等
  出版事項: (2015)
• Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
  著者:: Lequeux, Audrey, 等
  出版事項: (2021)
• EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction
  著者:: Akalay, Intissar, 等
  出版事項: (2013)